Daily Sepsis Research Analysis
Analyzed 31 papers and selected 3 impactful papers.
Summary
Analyzed 31 papers and selected 3 impactful articles.
Selected Articles
1. ZBP1-driven pyroptosis-associated alveolar macrophages exacerbate epithelial dysfunction in sepsis.
Integrative human–mouse analyses reveal a ZBP1-dependent subset of pyroptosis-associated alveolar macrophages that expands in sepsis-induced ALI and disrupts AT2 epithelial mitochondrial function and barrier integrity. Genetic Zbp1 deficiency dampens macrophage–epithelial inflammatory crosstalk, nominating ZBP1 as a therapeutic target.
Impact: Identifies a mechanistic driver of epithelial injury in human sepsis-induced ALI with cross-species validation, bridging single-cell discovery to functional causality.
Clinical Implications: Supports development of ZBP1 inhibitors or inflammasome-modulating strategies to protect alveolar epithelial integrity in sepsis-induced lung injury and informs biomarker discovery of pyroptosis-high endotypes.
Key Findings
- Single-cell RNA-seq identified an expanding subset of ZBP1-dependent pyroptosis-associated macrophages in sepsis-induced ALI.
- ZBP1 activation induced inflammasome assembly and macrophage pyroptosis that impaired AT2 mitochondrial function and barrier integrity.
- Zbp1 deficiency attenuated macrophage–AT2 inflammatory signaling and mitigated epithelial injury in septic lungs.
Methodological Strengths
- Cross-species integration of human BALF and murine lung single-cell datasets
- Functional validation via genetic Zbp1 deficiency demonstrating causality
Limitations
- Exact human sample sizes and cohort characteristics were not detailed in the abstract
- Therapeutic interventions targeting ZBP1 were not tested in clinical settings
Future Directions: Develop and test selective ZBP1 inhibitors; validate pyroptosis-associated macrophage signatures in larger human cohorts; explore combinatorial inflammasome modulation to preserve epithelial barrier.
The lung is highly vulnerable to inflammatory injury during sepsis, and acute lung injury (ALI) is a major cause of mortality in critically ill patients. Pyroptosis amplifies immune responses by promoting the release of inflammatory cytokines, and Z-DNA binding protein 1 (ZBP1) has emerged as a key upstream regulator of programmed cell death and inflammatory signaling. Nevertheless, the contribution of ZBP1 to human sepsis-induced ALI and its associated cellular programs remains poorly defined. Here, by integrating single-cell RNA sequencing data from bronchoalveolar lavage fluid (BALF) of patients with sepsis-induced ALI and from septic mouse lungs, we identified a distinct subset of pyroptosis-associated macrophages that expands during disease progression and exhibits ZBP1-dependent inflammasome activation. ZBP1 activation promoted inflammasome assembly, induced macrophage pyroptosis, and released pro-inflammatory mediators that impaired mitochondrial function and barrier integrity of alveolar type II (AT2) epithelial cells. ZBP1 deficiency markedly attenuated macrophage-AT2 inflammatory signaling and reduced the inflammatory amplification loop. Collectively, these findings identify ZBP1-mediated macrophage pyroptosis as a critical mechanism driving epithelial dysfunction during sepsis-induced ALI and provide a rationale for developing ZBP1-targeted strategies to restore immune-epithelial homeostasis and prevent organ failure in sepsis.In sepsis-induced acute lung injury, ZBP1 drives macrophage pyroptosis and amplifies inflammatory signaling, thereby promoting mitochondrial dysfunction, inflammatory activation, and barrier integrity loss in AT2 epithelial cells. Zbp1 deficiency suppresses macrophage pyroptosis, weakens macrophage-epithelial inflammatory crosstalk, and mitigates epithelial injury.
2. ER stress amplifies inflammation via a dual mechanism involving IκBζ-XBP1s synergism and Regnase-1 degradation.
ER stress amplifies inflammatory gene expression via two coordinated mechanisms: degrading Regnase-1 to stabilize Nfkbiz mRNA and enabling IκBζ–XBP1s transcriptional synergy, particularly boosting Il6 and Nos2. This synergy was required for excessive IL-6 production in septic mice, nominating IκBζ accumulation as a therapeutic target.
Impact: Provides a mechanistic bridge between proteotoxic ER stress and cytokine storm biology, identifying convergent transcriptional and post-transcriptional nodes with therapeutic potential.
Clinical Implications: Suggests targeting IκBζ–XBP1s cooperation or preventing Regnase-1 degradation to reduce IL-6–driven hyperinflammation in sepsis and ER stress–associated disorders.
Key Findings
- ER stress synergized with TLR signaling to markedly induce IκBζ in macrophages.
- Calcium-dependent signaling led to IKK-mediated Regnase-1 degradation, stabilizing Nfkbiz mRNA and accumulating IκBζ.
- IκBζ cooperated with XBP1s to drive Il6 and Nos2 transcription; this synergy was required for excessive IL-6 production in septic mice.
Methodological Strengths
- Mechanistic dissection across transcriptional and post-transcriptional layers
- In vitro macrophage and in vivo septic mouse validation of pathway function
Limitations
- Human validation beyond murine models was not reported in the abstract
- Pharmacologic targeting of the IκBζ–XBP1s or Regnase-1 axis was not tested in vivo
Future Directions: Develop small molecules or biologics to disrupt IκBζ–XBP1s interaction or stabilize Regnase-1; test efficacy in clinically relevant sepsis models and human primary cells.
Inflammatory diseases arise from complex interactions between immune signaling and cellular stress. Although endoplasmic reticulum (ER) stress is a key modulator of immunity, the mechanisms by which it promotes inflammatory pathology remain incompletely understood. Notably, ER stress-induced NF-κB activation alone is insufficient to account for robust IL-6 production, thus suggesting the involvement of additional regulators. Using bone marrow-derived macrophages and sepsis model mice, we identified the inducible transcription factor IκBζ as a critical mediator of this response, with ER stress synergizing with TLR signaling to markedly upregulate IκBζ. Mechanistically, ER stress triggered calcium-dependent signaling that led to IκB kinase-mediated degradation of the RNase Regnase-1, likely stabilizing Nfkbiz mRNA and promoting the accumulation of IκBζ, which was found to cooperate with the ER stress factor XBP1s to drive transcription of selected secondary-response genes, particularly Il6 and Nos2. Importantly, this synergy was required for excessive IL-6 production in septic mice, highlighting a gene-specific amplification pathway. Together, these findings identify a dual mechanism in which transcriptional synergy between IκBζ and XBP1s is coupled to posttranscriptional mRNA stabilization via Regnase-1 degradation, thereby linking proteotoxic stress to hyperinflammatory responses. Our results establish ER stress-mediated IκBζ accumulation as a key driver of inflammatory pathogenesis and a potential therapeutic target in ER stress-associated inflammatory disorders.
3. Disturbed metabolic adaptation drives natural killer cell dysfunction in association with nosocomial infection during human sepsis.
In human sepsis, NK cells exhibit sustained, cell-intrinsic metabolic dysfunction with reduced IL-12 receptor expression, impaired mTORC1 activation, and blunted IFN-γ responses, especially in patients who develop secondary infections. Pharmacologic AMPK inhibition restores mTORC1 activity and IFN-γ production ex vivo, highlighting a tractable metabolic checkpoint.
Impact: Links immunometabolic defects to clinically relevant secondary infections in sepsis and demonstrates reversible dysfunction, paving a path toward metabolic immunotherapy.
Clinical Implications: Supports risk stratification using NK-cell functional/metabolic readouts and motivates trials of metabolic modulators (e.g., AMPK–mTORC1 axis) to reduce nosocomial infections during sepsis recovery.
Key Findings
- NK cells from septic patients showed reduced IL-12 receptor expression and IFN-γ production for at least 14 days, especially in those with secondary infections.
- Dysfunction was cell-intrinsic, associated with impaired mTORC1 activation and reduced nutrient transporter expression.
- AMPK inhibition restored mTORC1 activity and increased IFN-γ production in NK cells ex vivo.
Methodological Strengths
- Longitudinal human sampling with functional readouts linked to secondary infection risk
- Mechanistic rescue experiments demonstrating reversibility via AMPK–mTORC1 pathway
Limitations
- Exploratory study with unspecified cohort size and potential single-center constraints
- No interventional clinical trial to test metabolic modulation in vivo
Future Directions: Validate NK metabolic defects as predictive biomarkers; conduct early-phase trials of metabolic modulators to restore NK function and prevent nosocomial infections.
BACKGROUND: Patients with sepsis are highly susceptible to detrimental nosocomial infections. During bacterial infection, natural killer (NK) cells release Interferon (IFN) γ that drives the elimination of invading pathogens. Interleukin (IL) 12 in synergy with other cytokines increases sensing and uptake of nutrients by NK cells for metabolic adaptation required for induction of IFN-γ production. We hypothesised that inappropriate function of NK cells was associated with nosocomial infections during human sepsis and linked to altered metabolic adaptation. METHODS: We performed a longitudinal exploratory study on circulating human NK cells during sepsis and evaluated adaptation of nutrient sensing, activation of the metabolic hub mammalian target of rapamycin (mTOR) C1, and IFN-γ production upon exposure to Staphylococcus aureus as a model for an opportunistic pathogen in vitro. The involvement of cell-intrinsic and extrinsic pathways in NK cell function was addressed. FINDINGS: Expression of the IL-12 receptor (p < 0.001) and downstream production of IFN-γ (p < 0.01) after exposure to S. aureus were suppressed in NK cells for at least 14 days after sepsis diagnosis, particularly in patients who developed secondary infections (p < 0.01). Mechanistically, suppression of NK cells was independent from environmental cues but was cell-intrinsic and associated with impaired activation of mTORC1 and with reduced expression of nutrient transporters required for anabolic metabolism. Inhibition of AMP kinase (AMPK) restored mTORC1 activity (p < 0.01) and increased the production of IFN-γ (p < 0.01) in NK cells from septic patients. INTERPRETATION: Defective metabolic regulation is associated with persistent NK cell dysfunction during human sepsis and might represent a potential therapeutic target to improve immune competence and decrease the risk for nosocomial infections. FUNDING: The study was supported by the "Research and Training" program "ELAN" for medical students of the medical faculty of the University Duisburg-Essen.